Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma
Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma
Active, not recruiting · NCT04417166 · Registry updated 2026-04-07Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pembrolizumab and Radiotherapy for Patients With NK/T Cell Lymphoma | Lymphoma, Extranodal NK-T-Cell, Neoplasms by Histologic Type, T-cell non-Hodgkin lymphoma, lymphoma, neoplasm | Active, not recruiting | Phase 2 | 2026-04-07 | NCT04417166 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| International Extranodal Lymphoma Study Group (IELSG) | 11 |
| Merck Sharp & Dohme LLC | 650 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Shanghai Rui-Jin Hospital | Shanghai | China | 1 |
| Sun Yat-Sen University Cancer Center | Guangzhou | China | 66 |